Louis W Sullivan insider trades: UNITED THERAPEUTICS (UTHR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Louis reports to the SEC






and 3 more companies
Open-market buys and sales
36 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | UTHR | ↓ Sell | 5,950 | $512.13 | $3.0M | by Trust | Dec 23, 2025 (1d) |
| Dec 18, 2024 | UTHR | ↓ Sell | 26,209 | $373.22 | $9.8M | Direct | Dec 19, 2024 (1d) |
| May 3, 2024 | UTHR | ↓ Sell | 5,160 | $258.39 | $1.3M | Direct | May 6, 2024 (3d) |
| Mar 1, 2023 | UTHR | ↓ Sell | 700 | $245.10 | $172K | Direct | Mar 2, 2023 (1d) |
| Feb 1, 2023 | UTHR | ↓ Sell | 700 | $261.33 | $183K | Direct | Feb 2, 2023 (1d) |
| Jan 3, 2023 | UTHR | ↓ Sell | 700 | $276.26 | $193K | Direct | Jan 3, 2023 (0d) |
| Dec 1, 2022 | UTHR | ↓ Sell | 700 | $279.89 | $196K | Direct | Dec 1, 2022 (0d) |
| Nov 1, 2022 | UTHR | ↓ Sell | 700 | $230.28 | $161K | Direct | Nov 2, 2022 (1d) |
| Oct 3, 2022 | UTHR | ↓ Sell | 710 | $211.56 | $150K | Direct | Oct 3, 2022 (0d) |
| Sep 2, 2022 | UTHR | ↓ Sell | 4,910 | $225.98 | $1.1M | Direct | Sep 6, 2022 (4d) |
| May 26, 2022 | UTHR | ↓ Sell | 6,310 | $225.00 | $1.4M | Direct | May 26, 2022 (0d) |
| Sep 2, 2020 | EBS | ↓ Sell | 28,418 | $111.22 | $3.2M | Direct | Sep 4, 2020 (2d) |
| Mar 4, 2020 | EBS | ↓ Sell | 7,893 | $58.96 | $465K | Direct | Mar 6, 2020 (2d) |
| May 13, 2016 | EBS | ↓ Sell | 47,631 | $39.21 | $1.9M | Direct | May 16, 2016 (3d) |
| May 11, 2016 | EBS | ↓ Sell | 9,969 | $39.25 | $391K | Direct | May 13, 2016 (2d) |
| Mar 11, 2016 | EBS | ↓ Sell | 14,879 | $34.03 | $506K | Direct | Mar 14, 2016 (3d) |
| Mar 10, 2016 | EBS | ↓ Sell | 14,820 | $35.34 | $524K | Direct | Mar 14, 2016 (4d) |
| Mar 2, 2016 | HSIC | ↓ Sell | 11,735 | $168.59 | $2.0M | Direct | Mar 3, 2016 (1d) |
| Nov 17, 2015 | HSIC | ↓ Sell | 15,622 | $154.13 | $2.4M | Direct | Nov 19, 2015 (2d) |
| Jun 18, 2015 | UTHR | ↓ Sell | 15,000 | $185.60 | $2.8M | Direct | Jun 22, 2015 (4d) |
| Jun 16, 2015 | EBS | ↓ Sell | 13,457 | $31.32 | $422K | Direct | Jun 17, 2015 (1d) |
| Aug 29, 2014 | HSIC | ↓ Sell | 17,262 | $119.99 | $2.1M | Direct | Sep 2, 2014 (4d) |
| May 22, 2014 | UTHR | ↓ Sell | 30,000 | $101.46 | $3.0M | Direct | May 23, 2014 (1d) |
| May 13, 2014 | HSIC | ↓ Sell | 1,638 | $116.01 | $190K | Direct | May 15, 2014 (2d) |
| Sep 30, 2013 | UTHR | ↓ Sell | 42,000 | $78.48 | $3.3M | Direct | Oct 1, 2013 (1d) |
| Aug 20, 2013 | HSIC | ↓ Sell | 15,000 | $103.91 | $1.6M | Direct | Aug 21, 2013 (1d) |
| Aug 15, 2011 | BPAX | ↑ Buy | 10,000 | $2.67 | $27K | Direct | Aug 29, 2011 (14d) |
| May 2, 2011 | UTHR | ↓ Sell10b5-1 | 6,000 | $66.96 | $402K | Direct | May 2, 2011 (0d) |
| Mar 15, 2011 | HSIC | ↓ Sell | 19,500 | $65.60 | $1.3M | Direct | Mar 16, 2011 (1d) |
| Mar 1, 2011 | UTHR | ↓ Sell10b5-1 | 6,000 | $67.39 | $404K | Direct | Mar 2, 2011 (1d) |
| Jan 13, 2011 | BPAX | ↑ Buy | 10,000 | $1.72 | $17K | Direct | Jan 14, 2011 (1d) |
| Jan 3, 2011 | UTHR | ↓ Sell10b5-1 | 6,000 | $63.93 | $384K | Direct | Jan 3, 2011 (0d) |
| Oct 29, 2010 | UTHR | ↓ Sell10b5-1 | 6,000 | $60.00 | $360K | Direct | Oct 29, 2010 (0d) |
| Aug 12, 2010 | UTHR | ↓ Sell10b5-1 | 24,000 | $50.50 | $1.2M | Direct | Aug 12, 2010 (0d) |
| Aug 9, 2010 | UTHR | ↓ Sell10b5-1 | 1,282 | $51.85 | $66K | Direct | Aug 9, 2010 (0d) |
| Dec 11, 2007 | UTHR | ↓ Sell | 20,213 | $105.29 | $2.1M | Direct | Dec 11, 2007 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other UTHR insiders
Open-market trades in the last 12 months
About Louis W Sullivan's insider trades
Louis W Sullivan is an insider at UNITED THERAPEUTICS (UTHR). Since Dec 11, 2007, Louis has reported 2 open-market purchases worth $44K and 34 sales worth $48.6M on SEC Form 4. In the last 12 months: 1 sale ($3.0M).
6 sales (6% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (87 filings), option exercises (61 filings), shares returned to the company (15 filings), shares withheld for taxes (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every UTHR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.